Acambis seen as takeover target

U.K. biotech firm Acambis is a likely takeover target in the wake of it missing out on a U.S. government contract for a smallpox vaccine, some shareholders say. Sanofi-Aventis and Baxter Healthcare are among the companies mentioned as potential buyers of all or part of Acambis.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX